A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
Pheast Therapeutics
NiKang Therapeutics, Inc.
Seagen Inc.
Pliant Therapeutics, Inc.
BioNTech SE
Eli Lilly and Company
Kivu Bioscience Inc.
MOMA Therapeutics
Kestrel Therapeutics, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OncoC4, Inc.
Compass Therapeutics
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
Fate Therapeutics
IDEAYA Biosciences
Agenus Inc.
Radiopharm Theranostics, Ltd
GlaxoSmithKline
SystImmune Inc.
Institut Paoli-Calmettes
AstraZeneca
Sutro Biopharma, Inc.
Accent Therapeutics
Myeloid Therapeutics
Tizona Therapeutics, Inc
SEED Therapeutics, Inc.
Dana-Farber Cancer Institute
Normunity AccelCo, Inc.
IDEAYA Biosciences
MacroGenics
SystImmune Inc.
Pheon Therapeutics
Doma Biopharmaceutical(Suzhou)Co., Ltd.
M.D. Anderson Cancer Center
Eli Lilly and Company
Seagen Inc.
Dren Bio
Sairopa B.V.
NextCure, Inc.
NeoTX Therapeutics Ltd.
Blueprint Medicines Corporation
West China Hospital
SystImmune Inc.
Incyte Corporation
NiKang Therapeutics, Inc.
EtiraRx Australia Pty Ltd